Back
Reshape Lifesciences Stock Price Chart
Mode Mobile Could be Next in Line
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
14
RSLS
Reshape Lifesciences
Last Price:
$0.31
Seasonality Move:
-20.69%
7 Day Trial
ALL ACCESS PASS
$
7
Major Market Shift - Act Now Before it's Too Late
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RSLS is experiencing slight selling pressure.
Reshape Lifesciences Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.42 | Sell |
| 20-day SMA: | 0.52 | Sell |
| 50-day SMA: | 1.07 | Sell |
| 200-day SMA: | 5.69 | Sell |
| 8-day EMA: | 0.43 | Sell |
| 20-day EMA: | 0.56 | Sell |
| 50-day EMA: | 1.29 | Sell |
| 200-day EMA: | 13.61 | Sell |
Reshape Lifesciences Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.21 | Sell |
| Relative Strength Index (14 RSI): | 41.28 | Sell |
| Chaikin Money Flow: | 374755 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.3 - 0.78) | Sell |
| Bollinger Bands (100): | (0.94 - 4.84) | Sell |
Reshape Lifesciences Technical Analysis
| Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Reshape Lifesciences Stock
Is Reshape Lifesciences Stock a Buy?
-
Reshape Lifesciences share price is 0.36 while RSLS 8-day simple moving average is 0.42, which is a Sell signal.
-
The stock price of RSLS is 0.36 while Reshape Lifesciences 20-day SMA is 0.52, which makes it a Sell.
-
Reshape Lifesciences 50-day simple moving average is 1.07 while RSLS share price is 0.36, making it a Sell technically.
-
RSLS stock price is 0.36 and Reshape Lifesciences 200-day simple moving average is 5.69, creating a Sell signal.
RSLS Technical Analysis vs Fundamental Analysis
Sell
14
Reshape Lifesciences (RSLS)
is a Sell
Is Reshape Lifesciences a Buy or a Sell?
-
Reshape Lifesciences stock is rated a SellThe current Reshape Lifesciences [RSLS] share price is $0.36. The Score for RSLS is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
Reshape Lifesciences Stock Info
Market Cap:
4.1M
Price in USD:
0.36
Share Volume:
2M
Reshape Lifesciences 52-Week Range
52-Week High:
29.00
52-Week Low:
0.30
Sell
14
Reshape Lifesciences (RSLS)
is a Sell
Reshape Lifesciences Share Price Forecast
-
What is the Reshape Lifesciences stock price today?The Reshape Lifesciences stock price is 0.36 USD today.
-
Will RSLS stock go up or go down?Reshape Lifesciences> share price is forecast to RISE/FALL based on technical indicators
-
Is Reshape Lifesciences overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Reshape Lifesciences is overvalued.
Is Reshape Lifesciences Stock a Buy?
-
Reshape Lifesciences share price is 0.36 while RSLS 8-day exponential moving average is 0.43, which is a Sell signal.
-
The stock price of RSLS is 0.36 while Reshape Lifesciences 20-day EMA is 0.56, which makes it a Sell.
-
Reshape Lifesciences 50-day exponential moving average is 1.29 while RSLS share price is 0.36, making it a Sell technically.
-
RSLS stock price is 0.36 and Reshape Lifesciences 200-day simple moving average is 13.61, creating a Sell signal.
Fundamental Analysis of Reshape Lifesciences
Is Reshape Lifesciences a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Reshape Lifesciences
Should I short Reshape Lifesciences stock?
-
RSLS Moving Average Covergence Divergence (MACD) indicator is -0.21, suggesting Reshape Lifesciences is a Sell
-
Reshape Lifesciences Relative Strength Index (RSI) is 41.28, which suggest Reshape Lifesciences is oversold
-
The Bollinger Bands (25) for Reshape Lifesciences is (0.3 - 0.78), which suggest Reshape Lifesciences is a Sell
-
The Bollinger Bands (100) for Reshape Lifesciences is (0.94 - 4.84), which suggest Reshape Lifesciences is a Sell
* Reshape Lifesciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.